Modern data on a combination of chronic obstructive pulmonary disease and osteoporosis

Author:

Pavlenko V. I.1,Schegortsova Y. Y.1,Bakina А. А.1

Affiliation:

1. Amur State Medical Academy

Abstract

Introduction. The development of systemic inflammation involving a number of organs and tissues with the implementation of pathophysiological mechanisms is an important characteristic of chronic obstructive pulmonary disease (COPD). Osteoporosis is one of the most serious and socially significant manifestation of the systemic effects of COPD. Osteoporosis limits the social activity of the patient and his family members, leads to high material costs and a high level of disability and mortality. Aim. To study the data of foreign and Russian studies on the prevalence of osteopenia, pathogenic mechanisms of development and the clinical meaning of osteoporosis in COPD. Materials and methods. The review includes literature data published mainly over the past five years in PubMed and eLibrary. Earlier publications were included in the review if necessary. Results. According to different authors, osteopenia occurs in 60-86.7% of patients with COPD. The degree of loss of mineral density of bones is proportional to the severity of COPD. Compression fractures of the spine and fractures and femoral neck are found in patients with COPD more often than in patients without COPD. Cytokines have a crucial role in the pathogenesis of the formation of osteoporosis in COPD. At the same time, studies are limited only by the significance of early response cytokines (interleukins 1 and 6, tumor necrosis factor-alpha). There are only single studies on the role of adipokines in bone remodeling with COPD. Conclusion. Further studies must be carried out for a deeper understanding of the mechanisms of regulating bone metabolism by cytokines and other immune factors in COPD. 

Publisher

Far Eastern Scientific Center Of Physiology and Pathology of Respiration

Subject

General Medicine

Reference55 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2021 Report). Available at: https://goldcopd.org/wpcontent/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf

2. Pavlenko V.I., Kolosov V.P., Naryshkina S.V. [Features of the comorbid course, prognosis and treatment of chronic obstructive pulmonary disease and coronary heart disease]. Blagoveshchensk; 2014 (in Russian). ISBN: 978-5-905864-07-0

3. Bakina A.A., Pavlenko V.I. [Chronic kidney disease as a manifestation of comorbidity in patients with chronic obstructive pulmonary disease]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2018; (69):115−122 (in Russian). https://doi.org/10.12737/article_5b985be86b47a1.51078145

4. Baranova I.A., Suleymanova A.K. [Osteoporosis and low-energy fractures in pulmonological patients: focus on chronic obstructive pulmonary disease]. Effektivnaya farmakoterapiya 2020; 16(19):52‒57 (in Russian). https://doi.org/10.33978/2307-3586-2020-16-19-52-57

5. Tanchenko O.A., Naryshkina S.V. [Obesity, metabolic disorders and hypertension in patients with chronic obstructive pulmonary disease: modern concepts of comorbidity (review)]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2016; (59):109‒118 (in Russian). https://cfpd.elpub.ru/jour/article/view/910

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3